跳转至内容
Merck
CN

219364-M

Cathepsin B, Human Liver

Cathepsin B, Human Liver, CAS 9047-22-7, is a purified native cathepsin B from human liver, purified by affinity chromatography. Upregulated in many types of tumors.

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.77
UNSPSC Code:
12352202
MDL number:
Specific activity:
≥50 units/mg protein
Assay:
>95% (SDS-PAGE and HPLC)
Biological source:
human liver
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human liver

description

Merck USA index - 14, 1905

assay

>95% (SDS-PAGE and HPLC)

form

liquid

specific activity

≥50 units/mg protein

purified by

affinity chromatography

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, avoid repeated freeze/thaw cycles

technique(s)

activity assay: suitable

pH range

3.5-6.0

suitability

suitable for molecular biology

application(s)

life science and biopharma

shipped in

wet ice

storage temp.

−70°C

Quality Level

Gene Information

human ... CTSB(1508)

General description

Research area: Cell Signaling

Cathepsin B, Human Liver, is a native cathepsin B from human liver, purified by affinity chromatography. Cathepsin B is a lysosomal protease with endo/exopeptidasecitation and a carboxydipeptidase activity. It is also known as cysteine cathepsin and belongs to the C1 family of papain-like enzymes. Cathepsin B like H, L, C, X, F, O and V is ubiquitously expressed in human tissues.

Optimal pH: 3.5-6.0.

Application

Cathepsin B, Human Liver has been used to assess its linker cleavage or proteolytic activity using an LC/MS MRM-based quantitation method.

Biochem/physiol Actions

Cathepsin B facilitates non-specific, bulk proteolysis within the acidic conditions of the endosomal/lysosomal compartment. Here, they break down both intracellular and extracellular proteins. Upregulation and secretion of cathepsin B have been shown to occur in many types of tumors and to correlate positively with their invasive and metastatic capabilities. Cathepsin B is shown to facilitate tumor invasion by dissolving extracellular barriers.

Packaging

Please refer to vial label for lot-specific concentration.

Physical form

In 50 mM sodium acetate buffer, 1 mM EDTA, pH 5.0.

Preparation Note

Following initial thaw, aliquot and freeze (-70°C).
Prepared from tissue of individuals that have been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Other Notes

Kostoulas, G., et al. 1999. FEBS Lett. 455, 286. Berquim, I.M., and Sloane, B.F. 1996. Adv. Exp. Med. Biol.389, 281. Keppler, D., et al. 1994. Biochim. Biophys. Acta.1226, 117. Musil, D., et al. 1991. EMBO J.10, 2321. Sloane B.F. 1990. Semin. Cancer Biol.1, 137.
One unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol Z-RR-βNA per min at 40°C, pH 6.0 in the presence of DTT.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持